Actively Recruiting
Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor
Led by Anhui Provincial Hospital · Updated on 2025-07-31
318
Participants Needed
2
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this real world study is to confirm the efficacy and saftey of Telpegfilgrastim injection for the prevention of chemotherapy-induced Neutropenia in Patients With Malignant solid tumor.
CONDITIONS
Official Title
Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female aged 18 to less than 70 years
- Body weight of at least 45 kg
- Histologically or cytologically confirmed malignant solid tumor
- Receiving a 3-week chemotherapy regimen with high risk of febrile neutropenia or moderate risk with increased neutropenia risk factors
- Karnofsky Performance Scale score of 70 or higher
- White blood cell count at least 3.5 �d7 10 9/L and absolute neutrophil count at least 1.5 �d7 10 9/L before chemotherapy
- Life expectancy of at least 6 months
- Willingness to comply with study protocol and provide written informed consent
You will not qualify if you...
- Received any other PEG-rhG-CSF within 4 weeks before the study
- Receiving intermittent or continuous chemotherapy such as albumin paclitaxel or capecitabine
- Previous or expected radiation therapy to more than 25% of total bone marrow
- Significant organ dysfunction including liver function (ALT, TBil) >2.5 times upper limit of normal or >5 times if liver metastasis present; hepatitis B or C infection or cirrhosis; renal function (creatinine) >1.5 times upper limit of normal
- Pregnant or breastfeeding women
- Hypersensitivity to rhG-CSF or other biological agents
- Any other conditions judged by investigators to affect study progress or results
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Anhui province hospital
Hefei, Anhui, China, 230000
Actively Recruiting
2
Anhui province hospital
Hefei, Anhui, China, 230000
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here